Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 5/2009

01.05.2009 | Original Paper

Diagnosis of unknown nonhematological tumors by bone marrow biopsy: a retrospective analysis of 10,112 samples

verfasst von: Li Xiao, Song Luxi, Tao Ying, Liu Yizhi, Wu Lingyun, Pu Quan

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate how unselected bone marrow (BM) biopsy examinations could help in the diagnosis of clinically unknown nonhematological tumors.

Methods

10,112 plastic-embedded BM biopsy sections were retrospectively analyzed. In the analysis we focused on the following aspects: (1) the frequency of BM involvement arising from clinically unknown nonhematological malignancies, (2) the clinical indication for BM biopsy examination in cases with tumor BM metastasis, (3) the primary sites of the metastatic tumors, and (4) the advantage of plastic-embedded biopsy sections over paraffin-embedded samples and the complementarity of biopsy with aspiration smears.

Results

Of the 10,112 BM samples analyzed, 101 (1.0%) were interpreted as being nonhematological tumor metastases. In cases with metastatic tumors, the nonhemocyte-related changes, such as skeletal pain (25%) and bone destruction (5%), were considerably higher than in those without metastasis (3.7 and 0.32%, respectively; < 0.001). Primary lesions were documented antemortem in 50 of the 101 biopsy-positive cases (49.5%); the most frequent being in the lung, gastric tract, and breast. Using this assay, a higher incidence of metastatic tumors was detected when compared with previously reported paraffin-embedded samples. The frequency of metastatic tumors based on aspiration smears when the positive results for biopsy sections were used as a reference was 74.3%. All the 101 sections with metastatic tumors showed various degrees of myelofibrosis.

Conclusions

We concluded that the routine BM biopsy examination is helpful in detecting insidious metastatic nonhematological malignancies. Skeletal pain and bone destruction are critical indications for susceptible patients to undergo BM examination. Plastic embedding of biopsy sections appears to be more sensitive than the paraffin embedding of samples and is an excellent complementation to isolated aspiration smears.
Literatur
Zurück zum Zitat Ellis LD, Jensen WN, Westerman MP (1964) Needle biopsy of bone and marrow: an experience with 1445 biopsies. Arch Intern Med 114:213–221PubMed Ellis LD, Jensen WN, Westerman MP (1964) Needle biopsy of bone and marrow: an experience with 1445 biopsies. Arch Intern Med 114:213–221PubMed
Zurück zum Zitat Fei Y, Jia-cheng X, Xiao-long J et al (2006) Pathologic diagnosis of bone marrow biopsy for metastatic carcinomas. J Shanghai Jiaotong Univ 26:444–447 Med Sci Fei Y, Jia-cheng X, Xiao-long J et al (2006) Pathologic diagnosis of bone marrow biopsy for metastatic carcinomas. J Shanghai Jiaotong Univ 26:444–447 Med Sci
Zurück zum Zitat Hiwada K, Sera Y, Nishimura M (1970) Autopsy case of secondary myelofibrosis due to bone marrow metastasis of stomach cancer. Lryo 24:585–590 Hiwada K, Sera Y, Nishimura M (1970) Autopsy case of secondary myelofibrosis due to bone marrow metastasis of stomach cancer. Lryo 24:585–590
Zurück zum Zitat Kemona A, Dzieciol J, Sulik M et al (1989) Neoplastic metastases in the bone marrow from cancers of the digestive system (stomach, pancreas, liver and gallbladder). Patol Pol 40:205–209PubMed Kemona A, Dzieciol J, Sulik M et al (1989) Neoplastic metastases in the bone marrow from cancers of the digestive system (stomach, pancreas, liver and gallbladder). Patol Pol 40:205–209PubMed
Zurück zum Zitat Maillefert JF, Tavernier C, Tebib J (2000) Determining the site of the primary cancer in patients with skeletal metastasis of unknown origin. Cancer 88:1759–1761. doi:10.1002/(SICI)1097-0142(20000401)88:7<1759::AID-CNCR33>3.0.CO;2-IPubMedCrossRef Maillefert JF, Tavernier C, Tebib J (2000) Determining the site of the primary cancer in patients with skeletal metastasis of unknown origin. Cancer 88:1759–1761. doi:10.1002/(SICI)1097-0142(20000401)88:7<1759::AID-CNCR33>3.0.CO;2-IPubMedCrossRef
Zurück zum Zitat Moid F, DePalma L (2005) Comparison of relative value of bone marrow aspirates and bone marrow trephine biopsies in the diagnosis of solid tumor metastasis and Hodgkin lymphoma: institutional experience and literature. Arch Pathol Lab Med 129:497–501PubMed Moid F, DePalma L (2005) Comparison of relative value of bone marrow aspirates and bone marrow trephine biopsies in the diagnosis of solid tumor metastasis and Hodgkin lymphoma: institutional experience and literature. Arch Pathol Lab Med 129:497–501PubMed
Zurück zum Zitat Naeim F (1998) Pathology of bone marrow, 2nd edn. Williams & Wilkins, Baltimore, pp 38–61 Naeim F (1998) Pathology of bone marrow, 2nd edn. Williams & Wilkins, Baltimore, pp 38–61
Zurück zum Zitat Papac RJ (1994a) Bone marrow metastases. A review. Cancer 74:2403–2413. doi:10.1002/1097-0142(19941101)74:9<2403::AID-CNCR2820740904>3.0.CO;2-FPubMedCrossRef Papac RJ (1994a) Bone marrow metastases. A review. Cancer 74:2403–2413. doi:10.1002/1097-0142(19941101)74:9<2403::AID-CNCR2820740904>3.0.CO;2-FPubMedCrossRef
Zurück zum Zitat Sabharwal BD, Malhotra VV, Aruna SS et al (1990) Comparative evaluation of bone marrow aspirate particle smears, imprints and biopsy sections. J Postgrad Med 36:194–198PubMed Sabharwal BD, Malhotra VV, Aruna SS et al (1990) Comparative evaluation of bone marrow aspirate particle smears, imprints and biopsy sections. J Postgrad Med 36:194–198PubMed
Zurück zum Zitat Takahashi T, Akihama T, Yamaguchi A et al (1987) Lysozyme secreting tumor: a case of gastric cancer associated with myelofibrosis due to disseminated bone marrow metastasis. Jpn J Med 26:58–64PubMed Takahashi T, Akihama T, Yamaguchi A et al (1987) Lysozyme secreting tumor: a case of gastric cancer associated with myelofibrosis due to disseminated bone marrow metastasis. Jpn J Med 26:58–64PubMed
Zurück zum Zitat Trillet-Lenoir VN, Arpin D, Brune J (1994) Bone marrow metastases detection in small cell lung cancer. A review. Anticancer Res 14:2795–2797PubMed Trillet-Lenoir VN, Arpin D, Brune J (1994) Bone marrow metastases detection in small cell lung cancer. A review. Anticancer Res 14:2795–2797PubMed
Metadaten
Titel
Diagnosis of unknown nonhematological tumors by bone marrow biopsy: a retrospective analysis of 10,112 samples
verfasst von
Li Xiao
Song Luxi
Tao Ying
Liu Yizhi
Wu Lingyun
Pu Quan
Publikationsdatum
01.05.2009
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 5/2009
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-008-0503-2

Weitere Artikel der Ausgabe 5/2009

Journal of Cancer Research and Clinical Oncology 5/2009 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.